Speaker: William Taft, MD

Title: “Next Steps for Adolescent Anxiety and Depression When SSRIs Are Not a Good Fit: SNRIs, Bupropion and Mirtazapine”

Learning Objectives

  1. Summarize the pediatric indications and evidence-based off-label uses for SNRIs, bupropion and mirtazapine
  2. Discuss pros and cons of adding bupropion or mirtazapine to a partially helpful SRI
  3. Describe dosing schedules and strategies for switching antidepressants
Session date: 
01/16/2024 - 12:15pm to 12:45pm CST
United States
  • 0.50 AMA PRA Category 1 Credit
  • 0.50 ANCC Contact Hours
  • 0.50 University of Wisconsin–Madison Continuing Education Hours
    • 0.50 Approved for AMA PRA Category 1 Credit™

Please login or register to take this course.
Discloser List CME Internal Report
William Taft, MD